SOPHARMA AD: Current report 71 buy back 30072015

opublikowano: 2015-07-31 11:10

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
Current_report_71_buy_back_30072015.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 71 / 2015
Date of issue: 2015-07-31
Short name of the issuer
SOPHARMA AD
Subject
Current report 71 buy back 30072015
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD hereby informs that from 23 July 2015 up to and including 28 July 2015 the Company bought 5000 own shares representing 0.0037% of the share capital of the Company, at a total value of 13 800.00 BGN on the Bulgarian Stock Exchange, the average price per share was 2.76 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 174 832, representing 3.84% of the share capital of the Company.
Annexes
File Description
Current report 71 buy back 30072015.docCurrent report 71 buy back 30072015.doc Current report 71 buy back 30072015

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2015-07-31 Ognian Donev Executive director